1-3 of 3
Masami Ishibashi
Close
Sort by
Journal Articles

A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Δ 12, 14 prostaglandin J 2 production

Hiroo Hasegawa, Yasuaki Yamada, Kanki Komiyama, Masahiko Hayashi, Masami Ishibashi, Toshiaki Sunazuka, Takeshi Izuhara, Kazuyuki Sugahara, Kazuto Tsuruda, Masato Masuda, Nobuyuki Takasu, Kunihiro Tsukasaki, Masao Tomonaga, Shimeru Kamihira
Journal: Blood
Blood (2007) 110 (5): 1664–1674.
https://doi.org/10.1182/blood-2007-01-068981
Published: 2007
Journal Articles

Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera , abrogates TRAIL resistance in leukemia cells

Hiroo Hasegawa, Yasuaki Yamada, Kanki Komiyama, Masahiko Hayashi, Masami Ishibashi, Tatsushi Yoshida, Toshiyuki Sakai, Takashi Koyano, Toh-Seok Kam, Ken Murata, Kazuyuki Sugahara, Kazuto Tsuruda, Norihiko Akamatsu, Kunihiro Tsukasaki, Masato Masuda, Nobuyuki Takasu, Shimeru Kamihira
Journal: Blood
Blood (2006) 107 (2): 679–688.
https://doi.org/10.1182/blood-2005-05-1982
Published: 2006
Journal Articles

Dihydroflavonol BB-1, an Extract of Natural Plant Blumea Balsamifera , Abrogates TRAIL Resistance in Adult T-Cell Leukemia/Lymphoma.

Hiroo Hasegawa, MD, Yasuaki Yamada, MD, phD, Masahiko Hayashi, phD, Masami Ishibashi, phD, Kanki Komiyama, phD, Ken Murata, MD, phD, Masato Masuda, MD, phD, Nobuyuki Takasu, MD, phD, Masao Tomonaga, MD, phD, Shimeru Kamihira, MD, phD
Journal: Blood
Blood (2004) 104 (11): 2290.
https://doi.org/10.1182/blood.V104.11.2290.2290
Published: 2004